High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?

被引:14
|
作者
Dreischulte, Tobias [1 ]
Guthrie, Bruce [1 ]
机构
[1] Univ Dundee Populat Hlth Sci, Kirsty Semple Way, Dundee, Scotland
关键词
adverse drug event; clinical decision support system; medication error; medication safety; performance feedback; primary healthcare;
D O I
10.1177/2042098612444867
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The safety of medication use in primary care is an area of increasing concern for health systems internationally. Systematic reviews estimate that 3-4% of all unplanned hospital admissions are due to preventable drug-related morbidity, the majority of which have been attributed to shortcomings in the prescribing and monitoring stages of the medication use process. We define high-risk prescribing as medication prescription by professionals, for which there is evidence of significant risk of harm to patients, and which should therefore either be avoided or (if avoidance is not possible) closely monitored and regularly reviewed for continued appropriateness. Although prevalence estimates vary depending on the instrument used, cross-sectional studies conducted in primary care equivocally show that it is common and there is evidence that it can be reduced. Quality improvement strategies, such as clinical decision support, performance feedback and pharmacist-led interventions have been shown to be effective in reducing prescribing outcomes but evidence of improved patient outcomes remains limited. The increasing implementation of electronic medical records in primary care offer new opportunities to combine different strategies to improve medication safety in primary care and to integrate services provided by different stakeholders. In this review article, we describe the spectrum of high-risk medication use in primary care, review approaches to its measurement and summarize research into its prevalence. Based on previously developed interventions to change professional practice, we propose a systematic approach to improve the safety of medication use in primary care and highlight areas for future research.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 50 条
  • [41] How high is a high risk? Prioritising high-risk individuals in an influenza pandemic
    Littmann, Jasper
    VACCINE, 2014, 32 (52) : 7167 - 7170
  • [42] HOW HIGH-SCHOOL PROGRAMS CAN BE IMPROVED
    DERTHICK, LG
    SCHOOL REVIEW, 1958, 66 (01): : 52 - 55
  • [43] How can components of common foods affect cancer risk?
    Senior, K
    MOLECULAR MEDICINE TODAY, 1997, 3 (03): : 103 - 107
  • [44] How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
    Stanciakova, Lucia
    Dobrotova, Miroslava
    Holly, Pavol
    Zolkova, Jana
    Vadelova, Lubica
    Skornova, Ingrid
    Ivankova, Jela
    Bolek, Tomas
    Samos, Matej
    Grendar, Marian
    Danko, Jan
    Kubisz, Peter
    Stasko, Jan
    DIAGNOSTICS, 2021, 11 (05)
  • [45] How can patient care be improved beyond medical treatment?
    Pagnoux, C
    Guillevin, L
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2005, 19 (02): : 337 - 344
  • [46] TRANSPORT OF HIGH-RISK NEONATE - WHO, WHEN, AND HOW
    HEIN, HA
    ERENBERG, AP
    LANE, N
    LUNDVALL, J
    JOURNAL OF THE IOWA MEDICAL SOCIETY, 1978, 68 (10): : 348 - 357
  • [47] How to manage high-risk acute myeloid leukemia
    E H Estey
    Leukemia, 2012, 26 : 861 - 869
  • [48] Interprofessional Care Conferences for High-Risk Primary Care Patients
    Weppner, William G.
    Davis, Kyle
    Sordahl, Jeffrey
    Willis, Janet
    Fisher, Amber
    Brotman, Adam
    Tivis, Rick
    Gordon, Tim
    Smith, C. Scott
    ACADEMIC MEDICINE, 2016, 91 (06) : 798 - 802
  • [49] How new imaging techniques can aid in defining the cardiovascular profile of the high-risk patient
    Bosi, S.
    Barbieri, A.
    Baldelli, M.
    Censi, S.
    Naldi, M.
    Squeri, A.
    Morozzi, C.
    Stefanutti, C.
    GIORNALE DI CHIRURGIA, 2012, 33 (11-12): : 429 - 434
  • [50] How to manage high-risk acute myeloid leukemia
    Estey, E. H.
    LEUKEMIA, 2012, 26 (05) : 861 - 869